| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 89,930 | 80,919 | 125,233 | 128,768 | | Cost of Revenue | 93,559 | 85,188 | 86,910 | 108,619 | | | Gross Profit | (3,629) | (4,269) | 38,323 | 20,149 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 10,508 | 10,355 | 9,098 | 17,440 | | Non Recurring |
-
| 29 |
-
|
-
| | Others |
-
| 155 |
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (302,921) | (14,808) | 29,225 | 2,709 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 32,739 | | Earnings Before Interest And Taxes | (11,252) | (15,083) | 29,225 | 36,657 | | Interest Expense | 12,332 | 6,131 | 7,274 | 7,879 | | Income Before Tax | (23,584) | (21,214) | 21,951 | 28,778 | | Income Tax Expense | (1,427) | (1,982) | 419 | (5,816) | | Minority Interest |
-
|
-
|
-
| (11,018) | | | | Net Income From Continuing Ops | (22,544) | (19,232) | 21,532 | 23,576 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (21,341) | (19,232) | 21,532 | 23,576 | | Preferred Stock And Other Adjustments | 3,210 | 5,828 | (9,038) |
-
| | | Net Income Applicable To Common Shares | ($18,131) | ($13,404) | $12,494 | $23,576 |
|
0.31% Nasdaq 0.00%
Income Statement
